Franklin Resources Inc Eagle Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$41.26 - $51.35 $99,931 - $124,369	-2,422 Reduced 28.18%	6,174 $275,000
Q4 2021 Feb 11, 2022	BUY	$45.82 - $56.9 $4,582 - $5,690	100 Added 1.18%	8,596 $438,000
Q3 2021 Nov 12, 2021	BUY	$43.79 - $55.78 $372,039 - $473,906	8,496 New	8,496 $473,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.